English | Español
Patient Daily | Dec 28, 2025

Biotech sector sees renewed momentum ahead of 2026 J.P. Morgan Healthcare Conference
Patient Daily | Dec 28, 2025

Novo Nordisk seeks FDA approval for combination obesity drug CagriSema
Patient Daily | Dec 28, 2025

GSK partners with CAMP4 Therapeutics on RNA drugs for neuro and kidney diseases
Patient Daily | Dec 28, 2025

Moderna receives $54 million from CEPI for avian flu vaccine development
Patient Daily | Dec 28, 2025

Voyager lays off staff following discontinuation of two programs by partner Novartis
Patient Daily | Dec 28, 2025

FDA may grant fast-track review vouchers to two Merck experimental drugs
Patient Daily | Dec 28, 2025

Four key questions pharma executives must ask before signing employment contracts
Patient Daily | Dec 28, 2025

Researchers find lung immune cells drive allergy-related inflammation

Trending
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

BioMarin pauses dosing and enrollment in two Voxzogo studies after safety signal
+ Regulatory
Patient Daily | Mar 20, 2026

Neurosurgeon DiGiorgio on 340B: '340B also takes money from taxpayers and makes everyone’s health insurance more expensive'
+ Pharmaceuticals
Patient Daily | Mar 22, 2026

FDA rejects REGENXBIO’s Hunter syndrome therapy as Denali awaits decision on rival drug
+ Pharmaceuticals
Patient Daily | Mar 25, 2026

Revolution and Ascendis identified as top buyout targets amid speculation of industry mega-merger